Decitabine/Cedazuridine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Decitabine/Cedazuridine, covering 2025-11-12 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) [Phase 1]